Public-registry site landscape for NCT04852172, a Acute Vaso Occlusive Crisis (VOC) study sponsored by Asklepion Pharmaceuticals, LLC. All data below is from public sources; Eichor is not affiliated with the sponsor.
| Trial | NCT04852172 (registry record) |
| Sponsor | Asklepion Pharmaceuticals, LLC |
| Condition(s) | Acute Vaso Occlusive Crisis (VOC) |
| Phase | PHASE1 / PHASE2 |
| Listed sites | 2 |
| Site countries | United States |
Eichor generates a preliminary site-risk snapshot for NCT04852172 — how the roster screens on competing-trial load, enrollment track record, and PI–indication fit — free, usually same day. Request it here →